3种品系小鼠iNKT细胞组织特异性分布

doi:10.3969/j.issn.1674-490X.2018.06.003

摘要/Abstract

摘要： 目的比较3种品系小鼠外周血、胸腺、脾脏和肝脏中iNKT细胞频率及胸腺、脾脏、肝脏iNKT细胞中iNKT1、iNKT2亚群比例的差异。方法分别以DBA/1、 NOD/LtJ 及C57BL/6J 3种品系小鼠为研究对象,分离健康小鼠外周血、胸腺、脾脏和肝脏的淋巴细胞,采用FCM检测各组织器官中TCR β和CD1d 四聚体双阳性的iNKT细胞频率,并根据核内PLZF和T-bet的表达水平确定iNKT1和iNKT2亚群。结果(1)3种品系小鼠外周血中iNKT细胞频率最低,肝脏中iNKT细胞频率最高,脾脏和胸腺iNKT细胞频率介于两者之间。其中,C57BL/6J 小鼠胸腺iNKT细胞频率显著低于DBA/1及NOD/LtJ小鼠,肝脏iNKT细胞频率显著高于其他2品系小鼠;NOD/LtJ小鼠脾脏、肝脏iNKT细胞频率显著低于C57BL/6J 及DBA/1小鼠。(2)3种品系小鼠胸腺iNKT细胞中iNKT2亚群占比较高,脾脏、肝脏中iNKT细胞以iNKT1亚群为主。其中,C57BL/6J小鼠胸腺iNKT2亚群比例最低;NOD/LtJ小鼠胸腺iNKT2亚群比例最高,脾脏、肝脏iNKT1亚群比例较高。结论 DBA/1、 NOD/LtJ 及C57BL/6J 3种品系小鼠,同一品系小鼠不同组织器官iNKT细胞频率及亚群比例,不同品系小鼠同一组织器官iNKT细胞频率及亚群比例存在很大差异。

关键词: 3种品系小鼠, iNKT细胞, iNKT1, iNKT2

Abstract: Objective To compare the rates of iNKT cells in peripheral blood, thymus, spleen, liver and the proportion of iNKT1, iNKT2 in thymus, spleen, liver respectively of three strains mice: DBA/1, NOD/LtJ and C57BL/6J. Methods Isolation of lymphocytes from peripheral blood, thymus, spleen and liver of mice. TCR β and CD1d tetramers were detected by using FCM to identify the rates of iNKT cells, endonuclear PLZF and T-bet were detected to confirm iNKT1 and iNKT2 subgroup in lymphocytes of these tissues. Results(1)The rates of iNKT cells was the lowest in the peripheral blood and the highest in the liver in all the three strains of mice.Compared with DBA/1 and NOD/LtJ mice, the rates of iNKT cells in C57BL/6J mice was lower in thymus, but was higher in liver. Compared with C57BL/6J and DBA/1 mice, the rates of iNKT cells in NOD/LtJ mice was lower in spleen and liver.(2)In all the three strains of mice, the proportion of iNKT2 was relatively high in thymus, iNKT1 was relatively high in spleen and liver. Among them, C57BL/6J mice was the lowest proportion of iNKT2 in thymus, and NOD/LtJ mice had the higher proportion of iNKT1 in spleen and liver. Conclusion In the DBA/1, NOD/LtJ and C57BL/6J mice, the rates and subpopulation ratio of iNKT cells were significantly different in different tissues of the same strain mice and in different strains mice of the same tissue.

Key words: three strains of mice, iNKT cells, iNKT1, iNKT2

中图分类号:

刘慧芳,高翔,赵会娟,陈胜德,孟明. 3种品系小鼠iNKT细胞组织特异性分布[J]. 医学研究与教育, 2018, 35(6): 10-18.

参考文献

[1] BRIGL M, BRENNER M B. CD1: antigen presentation and T cell function[J]. Annual Review of Immunology, 2004, 22(22):817-890.DOI: 10.1146/annurev.immunol.22.012703.104608.
[2] BENDELAC A, SAVAGE P B, TEYTON L. The biology of NKT cells[J]. Annual Review of Immunology, 2007, 25(1):297-336.DOI: 10.1146/annurev.immunol.25.022106.141711.
[3] GUMPERZ J E. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance[J]. Traffic, 2010,7(1):2-13.DOI: 10.1111/j.1600-0854.2005.00364.x.
[4] EXLEY M, GARCIA J, BALK S P, et al. Requirements for CD1d recognition by human invariant, Vα24⁺CD4^-CD8^-T Cells[J]. Journal of Experimental Medicine, 1997, 186(1):109-120.
[5] GUMPERZ J E, MIYAKE S, YAMAMURA T, et al. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining[J]. Journal of Experimental Medicine, 2002, 195(5):625-636.
[6] KAWANO T, CUI J, KOEZUKA Y, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides[J]. Science, 1997, 278(5343):1626-1629.
[7] VERVERS F A, KALKHOVEN E, VAN'T B L, et al. Immunometabolic activation of invariant natural killer T cells[J]. Frontiers in Immunology, 2018,9:1192.DOI: 10.3389/fimmu.2018.01192.
[8] BRENNAN P J, BRIGL M, BRENNER M B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions[J]. Nature Reviews Immunology, 2013, 13(2):101-117. DOI: 10.1038/nri3369.
[9] COHEN N R, GARG S, BRENNER M B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity[J]. Advances in Immunology, 2009, 102(5):1-94. DOI: 10.1016/S0065-2776(09)01201-2.
[10] KOHLGRUBER A C, DONADO C A, LAMARCHE N M, et al. Activation strategies for invariant natural killer T cells[J]. Immunogenetics, 2016, 68(8):1-15.DOI: 10.1007/s00251-016-0944-8.
[11] KIM E Y, LYNCH L, BRENNAN P J, et al. The transcriptional programs of iNKT cells[J]. Seminars in Immunology, 2015, 27(1):26-32. DOI: 10.1016/j.smim.2015.02.005.
[12] EGAWA T, EBERL G, TANIUCHI I, et al. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors[J]. Immunity, 2005, 22(6):705-716. DOI: 10.1016/j.immuni.2005.03.011.
[13] VAN EIJKEREN R J, KRABBE O, BOES M, et al. Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis[J]. Immunology, 2017, 153(2):179-189. DOI: 10.1111/imm.12839.
[14] WEI D G, LEE H, PARK S H, et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes[J]. Journal of Experimental Medicine, 2005, 202(2):239-248. DOI: 10.1084/jem.20050413.
[15] SAVAGE A K, CONSTANTINIDES M G, HAN J, et al. The Transcription factor PLZF directs the effector program of the NKT cell lineage[J]. Immunity, 2008, 29(3):391-403. DOI: 10.1016/j.immuni.2008.07.011.
[16] KOVALOVSKY D, UCHE O U, ELADAD S, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions[J]. Nature Immunology, 2008, 9(9):1055. DOI: 10.1038/ni.1641.
[17] LEE Y J, HOLZAPFEL K L, ZHU J, et al. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells[J]. Nature Immunology, 2013, 14(11):1146-1154. DOI: 10.1038/ni.2731.
[18] KWON D I, YOU J L. Lineage differentiation program of invariant natural killer T cells[J]. Immune Network, 2017, 17(6):365-377. DOI: 10.4110/in.2017.17.6.365.
[19] YOU J L, HAIGVANG W, GABRIEL J S, et al. Tissue-specific distribution of iNKT cells impacts their cytokine response[J]. Immunity, 2015, 43(3):566-578.DOI: 10.1016/j.immuni.2015.06.025.
[20] CROSBY C M, KRONENBERG M. Tissue-specific functions of invariant natural killer T cells[J]. Nature Reviews Immunology, 2018,18(9):559-574. DOI: 10.1038/s41577-018-0034-2.
[21] 刘嘉琳, 张雪娇, 杨飞,等. 免疫调节剂CH2b对葡萄糖-6-磷酸异构酶混合肽段诱导的类风湿性关节炎小鼠的影响[J]. 中国免疫学杂志, 2016, 32(8):1094-1098.
[22] 陈冬志, 尹晓琳, 刘嘉琳, 等. NOD/LtJ小鼠不同发病阶段iNKT细胞频率及亚群变化分析研究[J].中华微生物学和免疫学杂志,2018,38(5): 327-336. DOI: 10.3760/cma.j.issn.0254-5101.2018.05.002.
[23] BRENNAN P J, BRIGL M, BRENNER M B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions[J]. Nature Reviews Immunology, 2013, 13(2):101-117. DOI: 10.1038/nri3369.
[24] LYNCH L, MICHELET X, ZHANG S, et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg)cells and macrophages in adipose tissue[J]. Nature Immunology, 2015, 16(1):85-95. DOI: 10.1038/ni.3047.
[25] THOMAS S Y, SCANLON S T, GRIEWANK K G, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions[J]. Journal of Experimental Medicine, 2011, 208(6):1179-1188. DOI: 10.1084/jem.20102630.
[26] ZHAO H, YIN X, WANG Y, et al. The role of iNKT cells in chronic inflammation of obese adipose tissue[J]. Medical Research & Education, 2018,112(11):35.
[27] BENDELAC A. Positive selection of mouse NK1⁺ T cells by CD1-expressing cortical thymocytes[J]. Journal of Experimental Medicine, 1995, 182(6):2091-2096.
[28] COLES M C, RAULET D H. NK1.1⁺ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4⁺CD8⁺ cells[J]. Journal of Immunology, 2000, 164(5):2412-2418.
[29] GODFREY D I, MACDONALD H R, KRONENBERG M, et al. NKT cells: what's in a name?[J]. Nature Reviews Immunology, 2004, 4(3):231-237. DOI: 10.1038/nri1309.
[30] BENLAGHA K, KYIN T, BEAVIS A, et al. A thymic precursor to the NKT cell lineage[J]. Science, 2002, 296(5567):553-555.
[31] PELLICCI D G, HAMMOND K J L, ULDRICH A P, et al. A natural killer T(NKT)cell developmental pathway involving a thymus-dependent NK1.1^- CD4⁺CD1d^-dependent precursor stage[J]. Journal of Experimental Medicine, 2002, 195(7):835-844.